Prescribing Information en Español
LSM=least squares mean; SE=standard error.
Emma age 7
Later-onset (Type 3) SMAtreated with SPINRAZA
Individual results may vary based on several factors, including severity of disease, initiation of treatment, and duration of therapy.
1. Mercuri E, Darras BT, Chiriboga CA, et al; CHERISH Study Group. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625-635.